FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118026054> ?p ?o ?g. }

• W2118026054 endingPage "74" @default.
• W2118026054 startingPage "7066" @default.
• W2118026054 abstract "Here we describe the derivation of novel cell lines from spontaneous mammary tumors that arose in mouse mammary tumor virus-polyomavirus (MMTV-PyV) Middle T (MidT) transgenic mice. Clonal cell lines from four mixed cell populations were tested for adenovirus transducibility and sensitivity to p53 tumor suppressor gene therapy mediated by SCH58500, a replication-deficient adenovirus that expresses human p53. The MidT2-1 cell line was selected for further characterization in vitro and in vivo. This cell line carried the PyV MidT antigen, had wild-type p53 DNA, and was sensitive to suppression of proliferation by MMAC/PTEN tumor suppressor gene therapy. MidT2-1 cells gave rise to highly aggressive tumors in syngeneic FVB mice in both the mammary fat pad and the peritoneal cavity. The histopathology of MidT2-1 tumors closely resembled the histopathology of the primary transgenic tumors. Tumor growth in vivo was inhibited by p53 gene therapy or by MMAC gene therapy. In addition, combination therapy with a number of anticancer agents had synergistic or additive efficacy in vitro. In particular, MMAC gene therapy synergized with SCH58500 or paclitaxel. In the i.p. MidT2-1 tumor model p53 gene therapy enhanced the survival benefits of paclitaxel/cisplatin chemotherapy. Combination therapy has become a mainstay in cancer treatment. In this report, we use a novel transgenic mouse tumor cell line to suggest new combinations that might be explored in clinical cancer care. These include gene therapy using the tumor suppressors MMAC and p53, chemotherapy using farnesyl transferase inhibitors, the microtubule stabilizing taxanes, and the DNA synthesis disruptors gemcitabine and cisplatin. The precise biological mechanisms by which these therapies induce their antitumor effects are not fully elucidated. However, the work presented here suggests that many of these therapeutic approaches have synergistic antitumor activity when used in combination." @default.
• W2118026054 created "2016-06-24" @default.
• W2118026054 creator A5007710253 @default.
• W2118026054 creator A5033591612 @default.
• W2118026054 creator A5053969245 @default.
• W2118026054 creator A5069644079 @default.
• W2118026054 creator A5075068030 @default.
• W2118026054 creator A5078509616 @default.
• W2118026054 creator A5088689996 @default.
• W2118026054 creator A5073805596 @default.
• W2118026054 date "2000-12-15" @default.
• W2118026054 modified "2023-09-23" @default.
• W2118026054 title "Derivation and initial characterization of a mouse mammary tumor cell line carrying the polyomavirus middle T antigen: utility in the development of novel cancer therapeutics." @default.
• W2118026054 cites W1506576730 @default.
• W2118026054 cites W1552892110 @default.
• W2118026054 cites W1593855912 @default.
• W2118026054 cites W1594384581 @default.
• W2118026054 cites W1625966995 @default.
• W2118026054 cites W1637251086 @default.
• W2118026054 cites W1673025041 @default.
• W2118026054 cites W1963773878 @default.
• W2118026054 cites W1964311910 @default.
• W2118026054 cites W1968567648 @default.
• W2118026054 cites W1968965382 @default.
• W2118026054 cites W1974475356 @default.
• W2118026054 cites W1980935526 @default.
• W2118026054 cites W1983914017 @default.
• W2118026054 cites W1987892862 @default.
• W2118026054 cites W1989834582 @default.
• W2118026054 cites W1991865867 @default.
• W2118026054 cites W2005207212 @default.
• W2118026054 cites W2007204220 @default.
• W2118026054 cites W2008431826 @default.
• W2118026054 cites W2011378797 @default.
• W2118026054 cites W2024306318 @default.
• W2118026054 cites W2030573603 @default.
• W2118026054 cites W2032118018 @default.
• W2118026054 cites W2033734515 @default.
• W2118026054 cites W2037605675 @default.
• W2118026054 cites W2047761352 @default.
• W2118026054 cites W2048121649 @default.
• W2118026054 cites W2052582425 @default.
• W2118026054 cites W2057115166 @default.
• W2118026054 cites W2066260856 @default.
• W2118026054 cites W2066269784 @default.
• W2118026054 cites W2069764898 @default.
• W2118026054 cites W2072174486 @default.
• W2118026054 cites W2094068658 @default.
• W2118026054 cites W2097767970 @default.
• W2118026054 cites W2111449140 @default.
• W2118026054 cites W2111752734 @default.
• W2118026054 cites W2113255254 @default.
• W2118026054 cites W2114303119 @default.
• W2118026054 cites W2114918609 @default.
• W2118026054 cites W2126672062 @default.
• W2118026054 cites W2126679757 @default.
• W2118026054 cites W2127024723 @default.
• W2118026054 cites W2128984725 @default.
• W2118026054 cites W2137035181 @default.
• W2118026054 cites W2137242412 @default.
• W2118026054 cites W2152988906 @default.
• W2118026054 cites W2157191335 @default.
• W2118026054 cites W2167122324 @default.
• W2118026054 cites W2170427203 @default.
• W2118026054 cites W2268171795 @default.
• W2118026054 cites W2315222937 @default.
• W2118026054 cites W39787558 @default.
• W2118026054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11156413" @default.
• W2118026054 hasPublicationYear "2000" @default.
• W2118026054 type Work @default.
• W2118026054 sameAs 2118026054 @default.
• W2118026054 citedByCount "7" @default.
• W2118026054 countsByYear W21180260542016 @default.
• W2118026054 crossrefType "journal-article" @default.
• W2118026054 hasAuthorship W2118026054A5007710253 @default.
• W2118026054 hasAuthorship W2118026054A5033591612 @default.
• W2118026054 hasAuthorship W2118026054A5053969245 @default.
• W2118026054 hasAuthorship W2118026054A5069644079 @default.
• W2118026054 hasAuthorship W2118026054A5073805596 @default.
• W2118026054 hasAuthorship W2118026054A5075068030 @default.
• W2118026054 hasAuthorship W2118026054A5078509616 @default.
• W2118026054 hasAuthorship W2118026054A5088689996 @default.
• W2118026054 hasConcept C104317684 @default.
• W2118026054 hasConcept C111599444 @default.
• W2118026054 hasConcept C121608353 @default.
• W2118026054 hasConcept C2776187077 @default.
• W2118026054 hasConcept C2778264664 @default.
• W2118026054 hasConcept C502942594 @default.
• W2118026054 hasConcept C530470458 @default.
• W2118026054 hasConcept C54355233 @default.
• W2118026054 hasConcept C55493867 @default.
• W2118026054 hasConcept C555283112 @default.
• W2118026054 hasConcept C86803240 @default.
• W2118026054 hasConceptScore W2118026054C104317684 @default.
• W2118026054 hasConceptScore W2118026054C111599444 @default.
• W2118026054 hasConceptScore W2118026054C121608353 @default.
• W2118026054 hasConceptScore W2118026054C2776187077 @default.
• W2118026054 hasConceptScore W2118026054C2778264664 @default.

• next